Safety of SARS-CoV-2 Vaccines Assessed in Patients With Inflammatory and Noninflammatory Rheumatic and Musculoskeletal Diseases
Using data from the COVAX physician-reported registry, researchers studied the safety of SARS-CoV-2 vaccines in patients with inflammatory/autoimmune rheumatic and musculoskeletal diseases.